Importer of Controlled Substances Application: Cerilliant Corporation, 48506-48509 [2022-16994]
Download as PDF
48506
Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices
Controlled substance
Norfentanyl .....................................................................................................................................................................................
Phenylacetone ................................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ...............................................................................................................................................
Alphaprodine ..................................................................................................................................................................................
Cocaine ..........................................................................................................................................................................................
Codeine ..........................................................................................................................................................................................
Dihydrocodeine ...............................................................................................................................................................................
Oxycodone .....................................................................................................................................................................................
Hydromorphone ..............................................................................................................................................................................
Diphenoxylate .................................................................................................................................................................................
Ecgonine .........................................................................................................................................................................................
Ethylmorphine .................................................................................................................................................................................
Hydrocodone ..................................................................................................................................................................................
Levomethorphan .............................................................................................................................................................................
Levorphanol ....................................................................................................................................................................................
Isomethadone .................................................................................................................................................................................
Meperidine ......................................................................................................................................................................................
Meperidine intermediate-A .............................................................................................................................................................
Meperidine intermediate-B .............................................................................................................................................................
Meperidine intermediate-C .............................................................................................................................................................
Metazocine .....................................................................................................................................................................................
Methadone ......................................................................................................................................................................................
Methadone intermediate .................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................................
Morphine .........................................................................................................................................................................................
Thebaine .........................................................................................................................................................................................
Levo-alphacetylmethadol ................................................................................................................................................................
Oxymorphone .................................................................................................................................................................................
Noroxymorphone ............................................................................................................................................................................
Thiafentanil .....................................................................................................................................................................................
Racemethorphan ............................................................................................................................................................................
Alfentanil .........................................................................................................................................................................................
Remifentanil ....................................................................................................................................................................................
Sufentanil ........................................................................................................................................................................................
Carfentanil ......................................................................................................................................................................................
Tapentadol ......................................................................................................................................................................................
Fentanyl ..........................................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. In reference to dug codes
7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–17006 Filed 8–8–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
jspears on DSK121TN23PROD with NOTICES
[Docket No. DEA–1052]
Importer of Controlled Substances
Application: Cerilliant Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
VerDate Sep<11>2014
18:04 Aug 08, 2022
Jkt 256001
Cerilliant Corporation has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before September 8, 2022. Such
persons may also file a written request
for a hearing on the application on or
before September 8, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Drug
code
Schedule
8366
8501
8603
9010
9041
9050
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9250
9254
9273
9300
9333
9648
9652
9668
9729
9732
9737
9739
9740
9743
9780
9801
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on June 30, 2022,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
E:\FR\FM\09AUN1.SGM
09AUN1
48507
Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices
jspears on DSK121TN23PROD with NOTICES
Controlled substance
3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................................
Cathinone .......................................................................................................................................................................................
Methcathinone ................................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................................
Pentedrone (a-methylaminovalerophenone) ..................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ...................................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) ..............................................................................................................................................
Naphyrone ......................................................................................................................................................................................
N-Ethylamphetamine ......................................................................................................................................................................
N,N-Dimethylamphetamine ............................................................................................................................................................
Fenethylline ....................................................................................................................................................................................
Methaqualone .................................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ...............................................................
5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ...............................
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ....................................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .....................................................................................................................................
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ........................................................
THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ................................................................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ..............................
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................................
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ...........................................................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ..................................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ....................................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ......................................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .........................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ......................................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .....................................................................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ...........................................................................................
Alpha-ethyltryptamine .....................................................................................................................................................................
Ibogaine ..........................................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ...............................................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .........................................................
Lysergic acid diethylamide .............................................................................................................................................................
2C–T–7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ..............................................................................................................
Marihuana .......................................................................................................................................................................................
Parahexyl ........................................................................................................................................................................................
Mescaline .......................................................................................................................................................................................
2C–T–2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) .........................................................................................................
3,4,5-Trimethoxyamphetamine .......................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine .........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................................
2,5-Dimethoxyamphetamine ...........................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .....................................................................................................................
3,4-Methylenedioxyamphetamine ...................................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ......................................................................................................................................
3,4-Methylenedioxymethamphetamine ...........................................................................................................................................
4-Methoxyamphetamine .................................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................................
Alpha-methyltryptamine ..................................................................................................................................................................
Bufotenine ......................................................................................................................................................................................
Diethyltryptamine ............................................................................................................................................................................
Dimethyltryptamine .........................................................................................................................................................................
Psilocybin .......................................................................................................................................................................................
Psilocyn ..........................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ..................................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ...................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ..............................................................................................................................................
N-Benzylpiperazine ........................................................................................................................................................................
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ....................................................................................................................
2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) .................................................................................................................
2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ....................................................................................................................
2C–H 2-(2,5-Dimethoxyphenyl) ethanamine) .................................................................................................................................
2C–I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ........................................................................................................................
2C–C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ..................................................................................................................
VerDate Sep<11>2014
18:04 Aug 08, 2022
Jkt 256001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\09AUN1.SGM
09AUN1
Drug
code
Schedule
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
2565
6250
7008
7011
7012
7019
7023
7024
7031
7035
7048
7081
7104
7118
7122
7144
7173
7200
7201
7203
7222
7225
7249
7260
7297
7298
7315
7348
7360
7374
7381
7385
7390
7391
7392
7395
7396
7398
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7455
7458
7470
7493
7498
7508
7509
7517
7518
7519
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
48508
Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices
jspears on DSK121TN23PROD with NOTICES
Controlled substance
2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ...................................................................................................................
2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ............................................................................................................
2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ...................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ......................................................................................................................................
25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ...................................................................
25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ...................................................................
25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ........................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) .....................................................................................................................
Butylone ..........................................................................................................................................................................................
Pentylone ........................................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) .......................................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) .........................................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ..................................................................................................................
Desomorphine ................................................................................................................................................................................
Etorphine (except HCl) ...................................................................................................................................................................
Codeine methylbromide .................................................................................................................................................................
Heroin .............................................................................................................................................................................................
Morphine-N-oxide ...........................................................................................................................................................................
Normorphine ...................................................................................................................................................................................
Pholcodine ......................................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................................
Acetylmethadol ...............................................................................................................................................................................
Allylprodine .....................................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ....................................................................................................................
Alphameprodine .............................................................................................................................................................................
Alphamethadol ................................................................................................................................................................................
Betacetylmethadol ..........................................................................................................................................................................
Betameprodine ...............................................................................................................................................................................
Betamethadol .................................................................................................................................................................................
Betaprodine ....................................................................................................................................................................................
Dextromoramide .............................................................................................................................................................................
Dipipanone .....................................................................................................................................................................................
Hydroxypethidine ............................................................................................................................................................................
Noracymethadol .............................................................................................................................................................................
Norlevorphanol ...............................................................................................................................................................................
Normethadone ................................................................................................................................................................................
Racemoramide ...............................................................................................................................................................................
Trimeperidine ..................................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine .....................................................................................................................................
Tilidine ............................................................................................................................................................................................
Para-Fluorofentanyl ........................................................................................................................................................................
3-Methylfentanyl .............................................................................................................................................................................
Alpha-methylfentanyl ......................................................................................................................................................................
Acetyl-alpha-methylfentanyl ...........................................................................................................................................................
Beta-hydroxyfentanyl ......................................................................................................................................................................
Beta-hydroxy-3-methylfentanyl .......................................................................................................................................................
Alpha-methylthiofentanyl ................................................................................................................................................................
3-Methylthiofentanyl .......................................................................................................................................................................
Thiofentanyl ....................................................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ....................................................................................................
Methamphetamine ..........................................................................................................................................................................
Methylphenidate .............................................................................................................................................................................
Amobarbital ....................................................................................................................................................................................
Pentobarbital ..................................................................................................................................................................................
Secobarbital ....................................................................................................................................................................................
Glutethimide ...................................................................................................................................................................................
Nabilone .........................................................................................................................................................................................
1-Phenylcyclohexylamine ...............................................................................................................................................................
Phencyclidine .................................................................................................................................................................................
Phenylacetone ................................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ...............................................................................................................................................
Alphaprodine ..................................................................................................................................................................................
Dihydrocodeine ...............................................................................................................................................................................
Ecgonine .........................................................................................................................................................................................
Ethylmorphine .................................................................................................................................................................................
Levomethorphan .............................................................................................................................................................................
Levorphanol ....................................................................................................................................................................................
Meperidine ......................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................................
Levo-alphacetylmethadol ................................................................................................................................................................
Noroxymorphone ............................................................................................................................................................................
Racemethorphan ............................................................................................................................................................................
VerDate Sep<11>2014
18:04 Aug 08, 2022
Jkt 256001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\09AUN1.SGM
09AUN1
Drug
code
Schedule
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
9055
9056
9070
9200
9307
9313
9314
9547
9551
9601
9602
9603
9604
9605
9607
9608
9609
9611
9613
9622
9627
9633
9634
9635
9645
9646
9661
9750
9812
9813
9814
9815
9830
9831
9832
9833
9835
9850
1105
1724
2125
2270
2315
2550
7379
7460
7471
8501
8603
9010
9120
9180
9190
9210
9220
9230
9273
9648
9668
9732
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
48509
Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices
Controlled substance
Alfentanil .........................................................................................................................................................................................
Remifentanil ....................................................................................................................................................................................
Sufentanil ........................................................................................................................................................................................
Carfentanil ......................................................................................................................................................................................
Tapentadol ......................................................................................................................................................................................
The company plans to import the
listed controlled substances for the
manufacturing of analytical reference
standards and distribution to their
research and forensic customers. No
other activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–16994 Filed 8–8–22; 8:45 am]
BILLING CODE P
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on July 7, 2022, Experic
LLC, 2 Clarke Drive, Cranbury, New
Jersey 08512–3619, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Controlled substance
DEPARTMENT OF JUSTICE
Psilocybin ........................
Psilocyn ...........................
Drug
code
Schedule
7437
7438
I
I
Drug Enforcement Administration
[Docket No. DEA–1064]
Bulk Manufacturer of Controlled
Substances Application: Experic LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Experic LLC has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 11, 2022. Such
persons may also file a written request
for a hearing on the application on or
before October 11, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
jspears on DSK121TN23PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:04 Aug 08, 2022
Jkt 256001
The company plans to bulk
manufacture the listed controlled
substances for drug codes 7437
(Psilocybin) and 7438 (Psilocyn),
planning on germinating mushrooms to
be harvested and freeze dried in form of
powder to be filled into capsules for use
in clinical studies.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–17012 Filed 8–8–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1042]
Importer of Controlled Substances
Application: Sharp Clinical Services,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Frm 00059
Fmt 4703
Sfmt 4703
9737
9739
9740
9743
9780
II
II
II
II
II
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before September 8, 2022. Such
persons may also file a written request
for a hearing on the application on or
before September 8, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 23, 2022, Sharp
Clinical Services, LLC, 2400 Baglyos
Circle, Bethlehem, Pennsylvania 18020–
8024, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUMMARY:
PO 00000
Schedule
DATES:
Controlled substance
Sharp Clinical Services, LLC
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
Drug
code
5-Methoxy-N-Ndimethyltryptamine.
Drug
code
7431
Schedule
I
The company plans to import the
listed control substances for clinical
E:\FR\FM\09AUN1.SGM
09AUN1
Agencies
[Federal Register Volume 87, Number 152 (Tuesday, August 9, 2022)]
[Notices]
[Pages 48506-48509]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16994]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1052]
Importer of Controlled Substances Application: Cerilliant
Corporation
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cerilliant Corporation has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
September 8, 2022. Such persons may also file a written request for a
hearing on the application on or before September 8, 2022.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on June 30, 2022, Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered
as an importer of the following basic class(es) of controlled
substance(s):
[[Page 48507]]
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)............ 1233 I
Cathinone..................................... 1235 I
Methcathinone................................. 1237 I
4-Fluoro-N-methylcathinone (4-FMC)............ 1238 I
Pentedrone ([alpha]-methylaminovalerophenone). 1246 I
Mephedrone (4-Methyl-N-methylcathinone)....... 1248 I
4-Methyl-N-ethylcathinone (4-MEC)............. 1249 I
Naphyrone..................................... 1258 I
N-Ethylamphetamine............................ 1475 I
N,N-Dimethylamphetamine....................... 1480 I
Fenethylline.................................. 1503 I
Methaqualone.................................. 2565 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) 6250 I
indole).
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl- 7008 I
3-(2-methoxyphenylacetyl) indole).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7012 I
yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)....... 7019 I
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7023 I
yl)-1-pentyl-1H-indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7031 I
yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7035 I
2-yl)-1-pentyl-1H-indazole-3-carboxamide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H- 7048 I
indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) 7081 I
indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- 7104 I
methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3-(1- 7118 I
naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) 7122 I
indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)....... 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) 7201 I
indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) 7203 I
indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H- 7225 I
indole-3-carboxylate).
Alpha-ethyltryptamine......................... 7249 I
Ibogaine...................................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- 7297 I
hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)- 7298 I
2-[(1R,3S)3-hydroxycyclohexyl-phenol).
Lysergic acid diethylamide.................... 7315 I
2C-T-7 (2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine.
Marihuana..................................... 7360 I
Parahexyl..................................... 7374 I
Mescaline..................................... 7381 I
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine ).
3,4,5-Trimethoxyamphetamine................... 7390 I
4-Bromo-2,5-dimethoxyamphetamine.............. 7391 I
4-Bromo-2,5-dimethoxyphenethylamine........... 7392 I
4-Methyl-2,5-dimethoxyamphetamine............. 7395 I
2,5-Dimethoxyamphetamine...................... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) 7398 I
indole).
3,4-Methylenedioxyamphetamine................. 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine....... 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine....... 7402 I
3,4-Methylenedioxy-N-ethylamphetamine......... 7404 I
3,4-Methylenedioxymethamphetamine............. 7405 I
4-Methoxyamphetamine.......................... 7411 I
5-Methoxy-N-N-dimethyltryptamine.............. 7431 I
Alpha-methyltryptamine........................ 7432 I
Bufotenine.................................... 7433 I
Diethyltryptamine............................. 7434 I
Dimethyltryptamine............................ 7435 I
Psilocybin.................................... 7437 I
Psilocyn...................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine........... 7439 I
N-Ethyl-1-phenylcyclohexylamine............... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine............. 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine......... 7470 I
N-Benzylpiperazine............................ 7493 I
4-MePPP (4-Methyl- 7498 I
alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine).
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine)...... 7517 I
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine).
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine).
[[Page 48508]]
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)......... 7535 I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N- 7536 I
(2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N- 7537 I
(2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone...................................... 7541 I
Pentylone..................................... 7542 I
alpha-pyrrolidinopentiophenone ([alpha]-PVP).. 7545 I
alpha-pyrrolidinobutiophenone ([alpha]-PBP)... 7546 I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) 7694 I
indole).
Desomorphine.................................. 9055 I
Etorphine (except HCl)........................ 9056 I
Codeine methylbromide......................... 9070 I
Heroin........................................ 9200 I
Morphine-N-oxide.............................. 9307 I
Normorphine................................... 9313 I
Pholcodine.................................... 9314 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamide)).
Acetylmethadol................................ 9601 I
Allylprodine.................................. 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine................................ 9604 I
Alphamethadol................................. 9605 I
Betacetylmethadol............................. 9607 I
Betameprodine................................. 9608 I
Betamethadol.................................. 9609 I
Betaprodine................................... 9611 I
Dextromoramide................................ 9613 I
Dipipanone.................................... 9622 I
Hydroxypethidine.............................. 9627 I
Noracymethadol................................ 9633 I
Norlevorphanol................................ 9634 I
Normethadone.................................. 9635 I
Racemoramide.................................. 9645 I
Trimeperidine................................. 9646 I
1-Methyl-4-phenyl-4-propionoxypiperidine...... 9661 I
Tilidine...................................... 9750 I
Para-Fluorofentanyl........................... 9812 I
3-Methylfentanyl.............................. 9813 I
Alpha-methylfentanyl.......................... 9814 I
Acetyl-alpha-methylfentanyl................... 9815 I
Beta-hydroxyfentanyl.......................... 9830 I
Beta-hydroxy-3-methylfentanyl................. 9831 I
Alpha-methylthiofentanyl...................... 9832 I
3-Methylthiofentanyl.......................... 9833 I
Thiofentanyl.................................. 9835 I
Fentanyl related-compounds as defined in 21 9850 I
CFR 1308.11(h).
Methamphetamine............................... 1105 II
Methylphenidate............................... 1724 II
Amobarbital................................... 2125 II
Pentobarbital................................. 2270 II
Secobarbital.................................. 2315 II
Glutethimide.................................. 2550 II
Nabilone...................................... 7379 II
1-Phenylcyclohexylamine....................... 7460 II
Phencyclidine................................. 7471 II
Phenylacetone................................. 8501 II
1-Piperidinocyclohexanecarbonitrile........... 8603 II
Alphaprodine.................................. 9010 II
Dihydrocodeine................................ 9120 II
Ecgonine...................................... 9180 II
Ethylmorphine................................. 9190 II
Levomethorphan................................ 9210 II
Levorphanol................................... 9220 II
Meperidine.................................... 9230 II
Dextropropoxyphene, bulk (non-dosage forms)... 9273 II
Levo-alphacetylmethadol....................... 9648 II
Noroxymorphone................................ 9668 II
Racemethorphan................................ 9732 II
[[Page 48509]]
Alfentanil.................................... 9737 II
Remifentanil.................................. 9739 II
Sufentanil.................................... 9740 II
Carfentanil................................... 9743 II
Tapentadol.................................... 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
the manufacturing of analytical reference standards and distribution to
their research and forensic customers. No other activities for these
drug codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-16994 Filed 8-8-22; 8:45 am]
BILLING CODE P